04:54 PM EST, 11/26/2024 (MT Newswires) -- Iovance Biotherapeutics ( IOVA ) said late Tuesday it appointed Raj Puri to the newly created role of chief regulatory officer.
Puri joined the company in March 2022 as executive vice president of regulatory strategy and translational medicine.